10-Q Filing

REGENXBIO INC. CIK: 1590877 Q2 2021

Filing Information

Form Type	10-Q
Accession Number	`0001564590-21-042652`
Period End Date	20210630
Filing Date	20210809
Fiscal Year	2021
Fiscal Period	Q2
XBRL Instance	rgnx-10q_20210630_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 84 Income Statement 73 Cash Flow Statement 71 Stockholders Equity 31

Balance Sheet 84 line items

Line Item	Tag	Value	Unit	Period
Preferred stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	10.00M	shares	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	10.00M	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$257.07M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$338.43M	USD	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$94.22M	USD	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Marketable securities	`MarketableSecuritiesCurrent`	$137.31M	USD	Point-in-time
Marketable securities	`MarketableSecuritiesCurrent`	$117.67M	USD	Point-in-time
Accounts receivable, net	`AccountsReceivableNetCurrent`	$44.39M	USD	Point-in-time
Accounts receivable, net	`AccountsReceivableNetCurrent`	$43.00M	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	100.00M	shares	Point-in-time
Prepaid expenses	`PrepaidExpenseCurrent`	$13.09M	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	100.00M	shares	Point-in-time
Prepaid expenses	`PrepaidExpenseCurrent`	$10.51M	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$1.95M	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$5.16M	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	37.48M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	42.55M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	42.55M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$437.39M	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	37.48M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$531.20M	USD	Point-in-time
Marketable securities	`MarketableSecuritiesNoncurrent`	$218.22M	USD	Point-in-time
Marketable securities	`MarketableSecuritiesNoncurrent`	$46.81M	USD	Point-in-time
Accounts receivable, net	`AccountsReceivableNetNoncurrent`	$2.81M	USD	Point-in-time
Accounts receivable, net	`AccountsReceivableNetNoncurrent`	$3.27M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$56.47M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$106.69M	USD	Point-in-time
Operating lease right-of-use assets	`OperatingLeaseRightOfUseAsset`	$63.81M	USD	Point-in-time
Operating lease right-of-use assets	`OperatingLeaseRightOfUseAsset`	$62.28M	USD	Point-in-time
Restricted cash	`RestrictedCashAndCashEquivalentsNoncurrent`	$1.33M	USD	Point-in-time
Restricted cash	`RestrictedCashAndCashEquivalentsNoncurrent`	$1.33M	USD	Point-in-time
Restricted cash	`RestrictedCashAndCashEquivalentsNoncurrent`	$1.33M	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$5.28M	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$7.69M	USD	Point-in-time
Total assets	`Assets`	$836.40M	USD	Point-in-time
Total assets	`Assets`	$708.16M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$9.35M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$10.62M	USD	Point-in-time
Accrued expenses and other current liabilities	`AccruedExpensesAndOtherCurrentLiabilities`	$49.08M	USD	Point-in-time
Accrued expenses and other current liabilities	`AccruedExpensesAndOtherCurrentLiabilities`	$46.76M	USD	Point-in-time
Deferred revenue	`ContractWithCustomerLiabilityCurrent`	$449.00K	USD	Point-in-time
Deferred revenue	`ContractWithCustomerLiabilityCurrent`	$395.00K	USD	Point-in-time
Operating lease liabilities	`OperatingLeaseLiabilityCurrent`	$2.50M	USD	Point-in-time
Operating lease liabilities	`OperatingLeaseLiabilityCurrent`	$1.71M	USD	Point-in-time
Liability related to sale of future royalties	`LiabilityRelatedToSaleOfFutureRoyaltiesCurrent`	$18.79M	USD	Point-in-time
Liability related to sale of future royalties	`LiabilityRelatedToSaleOfFutureRoyaltiesCurrent`	$33.34M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$81.45M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$91.55M	USD	Point-in-time
Deferred revenue	`ContractWithCustomerLiabilityNoncurrent`	$3.78M	USD	Point-in-time
Deferred revenue	`ContractWithCustomerLiabilityNoncurrent`	$3.63M	USD	Point-in-time
Operating lease liabilities	`OperatingLeaseLiabilityNoncurrent`	$70.15M	USD	Point-in-time
Operating lease liabilities	`OperatingLeaseLiabilityNoncurrent`	$82.38M	USD	Point-in-time
Liability related to sale of future royalties	`LiabilityRelatedToSaleOfFutureRoyaltiesNonCurrent`	$151.08M	USD	Point-in-time
Liability related to sale of future royalties	`LiabilityRelatedToSaleOfFutureRoyaltiesNonCurrent`	$174.50M	USD	Point-in-time
Other liabilities	`OtherLiabilitiesNoncurrent`	$514.00K	USD	Point-in-time
Other liabilities	`OtherLiabilitiesNoncurrent`	$524.00K	USD	Point-in-time
Total liabilities	`Liabilities`	$330.41M	USD	Point-in-time
Total liabilities	`Liabilities`	$329.16M	USD	Point-in-time
Preferred stock; $0.0001 par value; 10,000 shares authorized, and no shares issued and outstanding at June 30, 2021 and December 31, 2020	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock; $0.0001 par value; 10,000 shares authorized, and no shares issued and outstanding at June 30, 2021 and December 31, 2020	`PreferredStockValue`	-	USD	Point-in-time
Common stock; $0.0001 par value; 100,000 shares authorized at March 31, 2020 and December 31, 2019; 37,190 and 36,992 shares issued and outstanding at March 31, 2020 and December 31, 2019, respectively	`CommonStockValue`	$4.00K	USD	Point-in-time
Common stock; $0.0001 par value; 100,000 shares authorized at March 31, 2020 and December 31, 2019; 37,190 and 36,992 shares issued and outstanding at March 31, 2020 and December 31, 2019, respectively	`CommonStockValue`	$4.00K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$667.18M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$905.35M	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-1.25M	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-360.00K	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-289.07M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-396.85M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$397.86M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$377.75M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$450.20M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$554.50M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$420.15M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$507.25M	USD	Point-in-time
Total liabilities and stockholders equity	`LiabilitiesAndStockholdersEquity`	$836.40M	USD	Point-in-time
Total liabilities and stockholders equity	`LiabilitiesAndStockholdersEquity`	$708.16M	USD	Point-in-time

Income Statement 73 line items

Line Item	Tag	Value	Unit	Period
Revenues	`RevenueFromContractWithCustomerExcludingAssessedTax`	$22.04M	USD	1 Quarter
Revenues	`RevenueFromContractWithCustomerExcludingAssessedTax`	$16.57M	USD	1 Quarter
Revenues	`RevenueFromContractWithCustomerExcludingAssessedTax`	$40.92M	USD	2 Qtrs
Revenues	`RevenueFromContractWithCustomerExcludingAssessedTax`	$34.21M	USD	2 Qtrs
Cost of revenues	`CostOfGoodsAndServicesSold`	$9.82M	USD	1 Quarter
Cost of revenues	`CostOfGoodsAndServicesSold`	$8.09M	USD	2 Qtrs
Cost of revenues	`CostOfGoodsAndServicesSold`	$14.67M	USD	2 Qtrs
Cost of revenues	`CostOfGoodsAndServicesSold`	$4.68M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$85.60M	USD	2 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$45.88M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$75.15M	USD	2 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$38.11M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$18.43M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$36.26M	USD	2 Qtrs
General and administrative	`GeneralAndAdministrativeExpense`	$15.55M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$30.39M	USD	2 Qtrs
Provision for credit losses and other	`ProvisionForCreditLossesAndOther`	$50.00K	USD	1 Quarter
Provision for credit losses and other	`ProvisionForCreditLossesAndOther`	$135.00K	USD	1 Quarter
Provision for credit losses and other	`ProvisionForCreditLossesAndOther`	$117.00K	USD	2 Qtrs
Provision for credit losses and other	`ProvisionForCreditLossesAndOther`	$650.00K	USD	2 Qtrs
Total operating expenses	`CostsAndExpenses`	$74.26M	USD	1 Quarter
Total operating expenses	`CostsAndExpenses`	$113.74M	USD	2 Qtrs
Total operating expenses	`CostsAndExpenses`	$137.19M	USD	2 Qtrs
Total operating expenses	`CostsAndExpenses`	$58.40M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-52.23M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-79.53M	USD	2 Qtrs
Loss from operations	`OperatingIncomeLoss`	$-41.83M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-96.27M	USD	2 Qtrs
Interest income from licensing	`InterestIncomeFromLicencing`	$554.00K	USD	1 Quarter
Interest income from licensing	`InterestIncomeFromLicencing`	$1.85M	USD	1 Quarter
Interest income from licensing	`InterestIncomeFromLicencing`	$2.70M	USD	2 Qtrs
Interest income from licensing	`InterestIncomeFromLicencing`	$583.00K	USD	2 Qtrs
Investment income	`InvestmentIncomeNet`	$979.00K	USD	2 Qtrs
Investment income	`InvestmentIncomeNet`	$5.72M	USD	1 Quarter
Investment income	`InvestmentIncomeNet`	$399.00K	USD	1 Quarter
Investment income	`InvestmentIncomeNet`	$2.54M	USD	2 Qtrs
Interest expense	`InterestExpense`	$13.07M	USD	2 Qtrs
Interest expense	`InterestExpense`	$6.37M	USD	1 Quarter
Total other income (expense)	`NonoperatingIncomeExpense`	$-11.51M	USD	2 Qtrs
Total other income (expense)	`NonoperatingIncomeExpense`	$7.57M	USD	1 Quarter
Total other income (expense)	`NonoperatingIncomeExpense`	$5.23M	USD	2 Qtrs
Total other income (expense)	`NonoperatingIncomeExpense`	$-5.41M	USD	1 Quarter
Loss before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-57.64M	USD	1 Quarter
Loss before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-74.30M	USD	2 Qtrs
Loss before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-107.77M	USD	2 Qtrs
Loss before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-34.26M	USD	1 Quarter
Income Tax Benefit (Expense)	`IncomeTaxExpenseBenefit`	$4.00K	USD	2 Qtrs
Income Tax Benefit (Expense)	`IncomeTaxExpenseBenefit`	$-500.00K	USD	2 Qtrs
Income Tax Benefit (Expense)	`IncomeTaxExpenseBenefit`	$-500.00K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-107.78M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-33.76M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-57.64M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-73.80M	USD	2 Qtrs
Unrealized gain (loss) on available-for-sale securities, net	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$113.00K	USD	1 Quarter
Unrealized gain (loss) on available-for-sale securities, net	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$1.33M	USD	1 Quarter
Unrealized gain (loss) on available-for-sale securities, net	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$-895.00K	USD	2 Qtrs
Unrealized gain (loss) on available-for-sale securities, net	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$545.00K	USD	2 Qtrs
Total other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$113.00K	USD	1 Quarter
Total other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$-895.00K	USD	2 Qtrs
Total other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$545.00K	USD	2 Qtrs
Total other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$1.33M	USD	1 Quarter
Comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-108.67M	USD	2 Qtrs
Comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-32.43M	USD	1 Quarter
Comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-57.53M	USD	1 Quarter
Comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-73.25M	USD	2 Qtrs
Net loss per share, basic and diluted	`EarningsPerShareBasicAndDiluted`	$-1.98	USD	2 Qtrs
Net loss per share, basic and diluted	`EarningsPerShareBasicAndDiluted`	$-0.91	USD	1 Quarter
Net loss per share, basic and diluted	`EarningsPerShareBasicAndDiluted`	$-2.56	USD	2 Qtrs
Net loss per share, basic and diluted	`EarningsPerShareBasicAndDiluted`	$-1.36	USD	1 Quarter
Weighted-average common shares outstanding, basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	42.51M	shares	1 Quarter
Weighted-average common shares outstanding, basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	37.18M	shares	2 Qtrs
Weighted-average common shares outstanding, basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	42.17M	shares	2 Qtrs
Weighted-average common shares outstanding, basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	37.26M	shares	1 Quarter

Cash Flow Statement 71 line items

Line Item	Tag	Value	Unit	Period
Net loss	`ProfitLoss`	$-73.80M	USD	2 Qtrs
Net loss	`ProfitLoss`	$-107.78M	USD	2 Qtrs
Stock-based compensation expense	`ShareBasedCompensation`	$16.33M	USD	2 Qtrs
Stock-based compensation expense	`ShareBasedCompensation`	$19.91M	USD	2 Qtrs
Depreciation and amortization	`DepreciationAndAmortization`	$4.13M	USD	2 Qtrs
Depreciation and amortization	`DepreciationAndAmortization`	$4.13M	USD	2 Qtrs
Provision for credit losses	`ProvisionForOtherCreditLosses`	-	USD	1 Quarter
Provision for credit losses	`ProvisionForOtherCreditLosses`	-	USD	1 Quarter
Provision for credit losses	`ProvisionForOtherCreditLosses`	-	USD	2 Qtrs
Provision for credit losses	`ProvisionForOtherCreditLosses`	$565.00K	USD	2 Qtrs
Net amortization of premiums on marketable debt securities	`AccretionAmortizationOfDiscountsAndPremiumsInvestments`	$-205.00K	USD	2 Qtrs
Net amortization of premiums on marketable debt securities	`AccretionAmortizationOfDiscountsAndPremiumsInvestments`	$-2.87M	USD	2 Qtrs
Net realized and unrealized losses (gains) on marketable securities	`NetRealizedOrUnrealizedGainLossOnMarketableSecurities`	$7.00K	USD	2 Qtrs
Net realized and unrealized losses (gains) on marketable securities	`NetRealizedOrUnrealizedGainLossOnMarketableSecurities`	$-704.00K	USD	2 Qtrs
Imputed interest income from licensing	`ImputedInterestIncomeFromLicensing`	$1.90M	USD	2 Qtrs
Imputed interest income from licensing	`ImputedInterestIncomeFromLicensing`	$231.00K	USD	2 Qtrs
Non-cash interest expense	`NonCashInterestExpense`	$13.07M	USD	2 Qtrs
Other non-cash adjustments	`OtherNoncashIncomeExpense`	$-373.00K	USD	2 Qtrs
Other non-cash adjustments	`OtherNoncashIncomeExpense`	$217.00K	USD	2 Qtrs
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$1.48M	USD	2 Qtrs
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$2.71M	USD	2 Qtrs
Prepaid expenses	`IncreaseDecreaseInPrepaidExpense`	$3.27M	USD	2 Qtrs
Prepaid expenses	`IncreaseDecreaseInPrepaidExpense`	$2.59M	USD	2 Qtrs
Other current assets	`IncreaseDecreaseInOtherCurrentAssets`	$3.11M	USD	2 Qtrs
Other current assets	`IncreaseDecreaseInOtherCurrentAssets`	$3.07M	USD	2 Qtrs
Operating lease right-of-use assets	`IncreaseDecreaseInOperatingLeaseRightOfUseAssets`	$-1.44M	USD	2 Qtrs
Operating lease right-of-use assets	`IncreaseDecreaseInOperatingLeaseRightOfUseAssets`	$-2.48M	USD	2 Qtrs
Other assets	`IncreaseDecreaseInOtherNoncurrentAssets`	$2.41M	USD	2 Qtrs
Other assets	`IncreaseDecreaseInOtherNoncurrentAssets`	$-1.35M	USD	2 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayableTrade`	$-847.00K	USD	2 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayableTrade`	$4.08M	USD	2 Qtrs
Accrued expenses and other current liabilities	`IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities`	$1.43M	USD	2 Qtrs
Accrued expenses and other current liabilities	`IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities`	$-5.88M	USD	2 Qtrs
Operating lease liabilities	`IncreaseDecreaseInOperatingLeaseLiabilities`	$-1.20M	USD	2 Qtrs
Operating lease liabilities	`IncreaseDecreaseInOperatingLeaseLiabilities`	$10.49M	USD	2 Qtrs
Other liabilities	`IncreaseDecreaseInOtherOperatingLiabilities`	$28.00K	USD	2 Qtrs
Other liabilities	`IncreaseDecreaseInOtherOperatingLiabilities`	$-1.17M	USD	2 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-57.07M	USD	2 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-71.00M	USD	2 Qtrs
Purchases of marketable debt securities	`PaymentsToAcquireMarketableSecurities`	$70.67M	USD	2 Qtrs
Purchases of marketable debt securities	`PaymentsToAcquireMarketableSecurities`	$241.99M	USD	2 Qtrs
Maturities of marketable debt securities	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$86.47M	USD	2 Qtrs
Maturities of marketable debt securities	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$146.35M	USD	2 Qtrs
Sales of marketable debt securities	`ProceedsFromSalesOfMarketableDebtSecurities`	$2.29M	USD	2 Qtrs
Sales of marketable equity securities	`ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities`	$7.12M	USD	2 Qtrs
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$50.86M	USD	2 Qtrs
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$7.91M	USD	2 Qtrs
Net cash provided by (used in) investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-206.38M	USD	2 Qtrs
Net cash provided by (used in) investing activities	`NetCashProvidedByUsedInInvestingActivities`	$77.19M	USD	2 Qtrs
Proceeds from exercise of stock options	`ProceedsFromStockOptionsExercised`	$3.98M	USD	2 Qtrs
Proceeds from exercise of stock options	`ProceedsFromStockOptionsExercised`	$1.57M	USD	2 Qtrs
Proceeds from issuance of common stock under employee stock purchase plan	`ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans`	$607.00K	USD	2 Qtrs
Proceeds from issuance of common stock under employee stock purchase plan	`ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans`	$627.00K	USD	2 Qtrs
Proceeds from public offering of common stock, net of underwriting discounts and commissions	`ProceedsFromIssuancesOfCommonStockNetOfUnderwritingDiscountsAndCommissions`	$216.44M	USD	2 Qtrs
Issuance costs for public offering of common stock	`PaymentsOfStockIssuanceCosts`	$379.00K	USD	2 Qtrs
Repayments under liability related to sale of future royalties	`RepaymentsUnderLiabilityRelatedToSaleOfFutureRoyalties`	$21.95M	USD	2 Qtrs
Transaction costs for sale of future royalties	`PaymentsOfTransactionCostsForSaleOfFutureLoyalties`	$265.00K	USD	2 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$4.59M	USD	2 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$196.03M	USD	2 Qtrs
Net increase (decrease) in cash and cash equivalents and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$24.71M	USD	2 Qtrs
Net increase (decrease) in cash and cash equivalents and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-81.35M	USD	2 Qtrs
Beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$258.40M	USD	Point-in-time
Beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$70.84M	USD	Point-in-time
Beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$339.76M	USD	Point-in-time
Beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$95.55M	USD	Point-in-time
End of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$258.40M	USD	Point-in-time
End of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$70.84M	USD	Point-in-time
End of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$339.76M	USD	Point-in-time
End of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$95.55M	USD	Point-in-time
Additions to property and equipment through accounts payable and accrued expenses	`CapitalExpendituresIncurredButNotYetPaid`	$3.52M	USD	2 Qtrs
Non-cash consideration received for licenses granted	`NoncashOrPartNoncashDivestitureAmountOfConsiderationReceived1`	$1.12M	USD	2 Qtrs

Stockholders Equity 31 line items

Line Item	Tag	Value	Unit	Period
Balances	`StockholdersEquity`	$397.86M	USD	Point-in-time
Balances	`StockholdersEquity`	$377.75M	USD	Point-in-time
Balances	`StockholdersEquity`	$450.20M	USD	Point-in-time
Balances	`StockholdersEquity`	$554.50M	USD	Point-in-time
Balances	`StockholdersEquity`	$420.15M	USD	Point-in-time
Balances	`StockholdersEquity`	$507.25M	USD	Point-in-time
Issuance of common stock upon public offering, net of transaction costs	`StockIssuedDuringPeriodValueNewIssues`	$216.06M	USD	2 Qtrs
Exercise of stock options	`StockIssuedDuringPeriodValueStockOptionsExercised`	$1.82M	USD	1 Quarter
Exercise of stock options	`StockIssuedDuringPeriodValueStockOptionsExercised`	$275.00K	USD	1 Quarter
Exercise of stock options	`StockIssuedDuringPeriodValueStockOptionsExercised`	$1.57M	USD	2 Qtrs
Exercise of stock options	`StockIssuedDuringPeriodValueStockOptionsExercised`	$3.98M	USD	2 Qtrs
Issuance of common stock under employee stock purchase plan	`StockIssuedDuringPeriodValueEmployeeStockPurchasePlan`	$607.00K	USD	2 Qtrs
Issuance of common stock under employee stock purchase plan	`StockIssuedDuringPeriodValueEmployeeStockPurchasePlan`	$627.00K	USD	2 Qtrs
Stock-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$19.91M	USD	2 Qtrs
Stock-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$8.32M	USD	1 Quarter
Stock-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$9.99M	USD	1 Quarter
Stock-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$16.33M	USD	2 Qtrs
Unrealized gain(loss) on available-for-sale securities, net	`OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax`	$113.00K	USD	1 Quarter
Unrealized gain(loss) on available-for-sale securities, net	`OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax`	$1.33M	USD	1 Quarter
Unrealized gain(loss) on available-for-sale securities, net	`OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax`	$-895.00K	USD	2 Qtrs
Unrealized gain(loss) on available-for-sale securities, net	`OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax`	$545.00K	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-107.78M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-33.76M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-57.64M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-73.80M	USD	2 Qtrs
Balances	`StockholdersEquity`	$397.86M	USD	Point-in-time
Balances	`StockholdersEquity`	$377.75M	USD	Point-in-time
Balances	`StockholdersEquity`	$450.20M	USD	Point-in-time
Balances	`StockholdersEquity`	$554.50M	USD	Point-in-time
Balances	`StockholdersEquity`	$420.15M	USD	Point-in-time
Balances	`StockholdersEquity`	$507.25M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.